Halozyme Therapeutics News, Halozyme Therapeutics Quote, HALO Quote

Halozyme Therapeutics (NQ:HALO) Delayed: 112.45 +2.77 (2.53%)

Prev. Close

$109.68

Today 6M 1Y 5Y

Open

$109.72

52 Wk High

$18.39

52 Wk Low

$6.96

Day High

$112.66

Day Low

$109.38

P/E

N/A

EPS

$-0.58

Volume

10,348,948

Friends, Peers and Foes (?): ORKA, RBND, VRTX, MRUS, ABBV (more...)

ALERTS | RSS

Sep 18, 2026 08:23 AM Form 8-K HALOZYME THERAPEUTICS, For: Sep 17
Sep 17, 2026 11:20 PM Halozyme prices $1.3B convertible notes offering due 2033
Sep 17, 2026 11:20 PM Halozyme Therapeutics, Inc. Announces Pricing of Upsized Private Offering of $1.3 Billion of Convertible Senior Notes due 2033
Sep 17, 2026 05:20 PM Form 4 HALOZYME THERAPEUTICS, For: Sep 16 Filed by: Posard Matthew L.
Sep 16, 2026 04:41 PM Form 144 HALOZYME THERAPEUTICS, Filed by: Posard Matthew L.
Sep 16, 2026 04:32 PM Form 8-K HALOZYME THERAPEUTICS, For: Sep 16
Sep 16, 2026 04:30 PM Halozyme proposes $1.05 billion convertible notes offering
Sep 16, 2026 04:30 PM Halozyme Therapeutics, Inc. Announces Proposed Offering of $1.05 Billion of Convertible Senior Notes due 2033
Sep 11, 2026 08:35 PM Form 4 HALOZYME THERAPEUTICS, For: Sep 09 Filed by: Torley Helen
Sep 3, 2026 06:58 AM H.C. Wainwright Reiterates Buy Rating on Halozyme Therapeutics (HALO)

Entities mentioned with HALO

View All Entities